112446-08-9

Upstream product

• 137023-12-2 2-(3-Methyl-2,4,5-trimethoxyphenyl)methyl-4-oxo-7,9,10-trimethoxy-8,11-dimethyl-(1α,2β,5α)-1,2,3,4,5,6-hexahydro-1,5-imino-3-benzazocine 
• 137023-10-0 2-(3-Methyl-2,4,5-trimethoxyphenyl)methyl-3-(phenyl)methyl-4-oxo-7,9,10-trimethoxy-8-methyl-(1α,2β,5α)-1,2,3,4,5,6-hexahydro-1,5-imino-3-benzazocine 
• 137023-11-1 2-(3-Methyl-2,4,5-trimethoxyphenyl)methyl-3-(phenyl)methyl-4-oxo-7,9,10-trimethoxy-8,11-dimethyl-(1α,2β,5α)-1,2,3,4,5,6-hexahydro-1,5-imino-3-benzazocine 
• 137023-08-6 2-(3-Methyl-2,4,5-trimethoxyphenyl)methyl-3-(phenyl)methyl-4-oxo-7,9,10-trimethoxy-8-methyl-11-(phenyl)methyl-(1α,2β,5α)-1,2,3,4,5,6-hexahydro-1,5-imino-3-benzazocine 
• 137023-07-5 1,4-Bis-(phenyl)methyl-3,6-bis-(2,4,5-trimethoxy-3-methylphenyl)methyl-(3α,6α)-piperazinedione 
• 137043-31-3 3,6-Bis-(2,4,5-trimethoxy-3-methylphenyl)methyl-piperazinedione 
• 115792-74-0 (E)-3-benzyl-2-<(2,4,5-trimethoxy-3-methylphenyl)-methylene>-7,9,10-trimethoxy-8,11-dimethyl-1,2,3,4,5,6-hexahydro-1,5-imino-3-benzazocine 
• 113461-95-3 11-Benzyl-3,4,6-trimethoxy-5-methyl-12-[1-(2,4,5-trimethoxy-3-methyl-phenyl)-meth-(E)-ylidene]-11,13-diaza-tricyclo[7.3.1.0^2,7]trideca-2⁽⁷⁾,3,5-trien-10-one 
• 113461-80-6 (Z)-4-benzyl-6-<(2,4,5-trimethoxy-3-methylphenyl)-methyl>-3-<(2,4,5-trimethoxy-3-methylphenyl)methylene>-2,5-piperazinedione 
• 113531-73-0 (E)-3-benzyl-2-<(2,4,5-trimethoxy-3-methylphenyl)-methylene>-7,9,70-trimethoxy-8,11-dimethyl-1,2,3,4,5,6-hexahydro-1,5-imino-3-benzazocine 
• 113461-81-7 (Z)-4-benzyl-1-(methoxycarbonyl)-6-<(2,4,5-trimethoxy-3-methylphenyl)methyl>-3-<(2,4,5-trimethoxy-3-methylphenyl)methylene>-2,5-piperazinedione 
• 113479-98-4 (Z)-4-benzyl-1-<(isopropyloxy)carbonyl>-6-<2,4,5-trimethoxy-3-methylphenyl)methyl>-3-<(2,4,5-trimethoxy-3-methylphenyl)methylene>-2,5-piperazinedione 
• 113461-84-0 (Z)-4-benzyl-1-(tert-butoxycarbonyl)-6-<(2,4,5-trimethoxy-3-methylphenyl)methyl>-3-<(2,4,5-trimethoxy-3-methylphenyl)methylene>-2,5-piperazinedione 
• 113461-91-9 (E)-3-benzyl-2-<(2,4,5-trimethoxy-3-methylphenyl)-methylene>-7,9,10-trimethoxy-8-methyl-4-oxo-1,2,3,4,5,6-hexahydro-1,5-imino-3-benzazocine-11-carboxylic acid isopropyl ester 

Downstream Products

• 112446-09-0 Butoxy-[(1S,9R,12R)-3,4,6-trimethoxy-5,13-dimethyl-12-(2,4,5-trimethoxy-3-methyl-benzyl)-11,13-diaza-tricyclo[7.3.1.0^2,7]trideca-2⁽⁷⁾,3,5-trien-11-yl]-acetic acid butyl ester 
• 112446-09-0 Butoxy-[(1S,9S,12S)-3,4,6-trimethoxy-5,13-dimethyl-12-(2,4,5-trimethoxy-3-methyl-benzyl)-11,13-diaza-tricyclo[7.3.1.0^2,7]trideca-2⁽⁷⁾,3,5-trien-11-yl]-acetic acid butyl ester 
• 66082-28-8 (+/-)-saframycin B 
• 115678-28-9 3-<2-<(2,4,5-trimethoxy-3-methylphenyl)methyl>>-7,9,10-trimetoxy-8,11-dimethyl-3-(ethoxyoxalyl)-(1α,2α,5α)-1,2,3,4,5,6-hexahydro-1,5-imino-3-benzazocine 
• 115678-27-8 2-<(2,4,5-trimethoxy-3-methylphenyl)methyl>-7,9,10-trimethoxy-8,11-dimethyl-3-(phthalimidoacetyl)-(1α,2α,5α)-1,2,3,4,5,6-hexahydro-1,5-imino-3-benzazocine 

Relevant academic research and scientific papers

Synthetic studies on saframycin anibiotics: an improved synthesis of tricyclic lactam intermediate and construction of the core ring system of saframycin A

An improved synthesis of the tricyclic lactam intermediate of saframycin antibiotics and the construction of the core ring system having a cyano group at C-21 position were presented.1 The stereochemistry of several key intermediates was determined by X-r

Saframycin synthetic studies

A conceptually simple and direct synthetic route to racemic saframycyn B, a bis-isoquinoline quinone antitumor antibiotic, was studied relying on transformations of a key C-2 symmetric intermediate.